Last reviewed · How we verify
Haemophilus b Conjugate Vaccine
Haemophilus b Conjugate Vaccine is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently FDA-approved.
Haemophilus b Conjugate Vaccine, marketed by Sanofi Pasteur, holds a significant position in the pediatric vaccine market. The key composition patent is set to expire in 2028, providing a strong competitive barrier until then. The primary risk lies in potential generic competition post-patent expiry, which could erode market share and revenue.
At a glance
| Generic name | Haemophilus b Conjugate Vaccine |
|---|---|
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Modified Tumor-free Techniques Operation to Cervical Cancer (NA)
- Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance (NA)
- Left Atrial Appendage Closure With Versus Without Pulsed Field Ablation in Atrial Fibrillation Patients With Mild Symptoms and High Stroke Risk (NA)
- Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases (PHASE2, PHASE3)
- HCL001 Cell Injection for Decompensated Cirrhosis: A Phase I/II Trial (PHASE1, PHASE2)
- A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE) (PHASE3)
- Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant (PHASE3)
- Exploratory Clinical Study of MT-2301 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Haemophilus b Conjugate Vaccine CI brief — competitive landscape report
- Haemophilus b Conjugate Vaccine updates RSS · CI watch RSS
- Sanofi Pasteur, a Sanofi Company portfolio CI